These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 33122391)
1. Differentiating MHC-Dependent and -Independent Mechanisms of Lymph Node Stromal Cell Regulation of Proinsulin-Specific CD8 Thayer TC; Davies J; Pearson JA; Hanna SJ; Wen L; Wong FS Diabetes; 2021 Feb; 70(2):529-537. PubMed ID: 33122391 [TBL] [Abstract][Full Text] [Related]
2. Peripheral Proinsulin Expression Controls Low-Avidity Proinsulin-Reactive CD8 T Cells in Type 1 Diabetes. Thayer TC; Pearson JA; De Leenheer E; Hanna SJ; Boldison J; Davies J; Tsui A; Ahmed S; Easton P; Siew LK; Wen L; Wong FS Diabetes; 2016 Nov; 65(11):3429-3439. PubMed ID: 27495224 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice. Postigo-Fernandez J; Farber DL; Creusot RJ Diabetologia; 2019 Nov; 62(11):2040-2051. PubMed ID: 31486854 [TBL] [Abstract][Full Text] [Related]
4. Lymph Node Stromal Cell-Intrinsic MHC Class II Expression Promotes MHC Class I-Restricted CD8 T Cell Lineage Conversion to Regulatory CD4 T Cells. Honan AM; Vazquez EN; Chen Z J Immunol; 2021 Sep; 207(6):1530-1544. PubMed ID: 34408011 [TBL] [Abstract][Full Text] [Related]
5. Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice. Levisetti MG; Lewis DM; Suri A; Unanue ER Diabetes; 2008 Jul; 57(7):1852-60. PubMed ID: 18398138 [TBL] [Abstract][Full Text] [Related]
6. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058 [TBL] [Abstract][Full Text] [Related]
7. Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8+ T Cells. Pearson JA; Thayer TC; McLaren JE; Ladell K; De Leenheer E; Phillips A; Davies J; Kakabadse D; Miners K; Morgan P; Wen L; Price DA; Wong FS Diabetes; 2016 Jun; 65(6):1679-89. PubMed ID: 26953160 [TBL] [Abstract][Full Text] [Related]
14. Genetic and therapeutic control of diabetogenic CD8+ T cells. Santamaria P Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463 [TBL] [Abstract][Full Text] [Related]
15. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes. Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194 [TBL] [Abstract][Full Text] [Related]
17. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897 [TBL] [Abstract][Full Text] [Related]
18. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. Martinez NR; Augstein P; Moustakas AK; Papadopoulos GK; Gregori S; Adorini L; Jackson DC; Harrison LC J Clin Invest; 2003 May; 111(9):1365-71. PubMed ID: 12727928 [TBL] [Abstract][Full Text] [Related]
19. In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice. Ciré S; Da Rocha S; Ferrand M; Collins MK; Galy A Mol Ther; 2016 Nov; 24(11):1965-1973. PubMed ID: 27562586 [TBL] [Abstract][Full Text] [Related]
20. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice. Matsumoto Y; Kishida K; Matsumoto M; Matsuoka S; Kohyama M; Suenaga T; Arase H Biochem Biophys Res Commun; 2021 Jan; 534():680-686. PubMed ID: 33208230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]